Adverse reactions to antiretroviral drugs in patients receiving therapy in a Federal teaching hospital Southwest Nigeria
Afrischolar Discovery · 16.11.2023
DOI: 10.60787/wapcp-25-2-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Afrischolar Discovery, erschienen am 16.11.2023. Verfasst von Sikiru Olatunji Usman und 13 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Antiretroviral drugs have proven efficacy in reducing viral load to undetectable plasma levels. Although, adverse reactions to antiretroviral drugs may cause death, prolongation of hospitalization, nonadherence and treatment failure in HIV infected persons; they are not fully documented in Nigeria. It is therefore necessary to evaluate adverse reactions of patients to antiretroviral drugs in Nigeria.
Objectives
This study aimed to document the adverse reactions to antiretroviral drugs (ARVs) in HIV-positive patients, assess their severity causality and identify the risk factors for the development of the ADRs.
Methods
With the aid of data capture form and interview, information about ADR was obtained prospectively from 51 new patients eligible to commence ARV for a period of 3 months. The retrospective arm made use of information extracted from the case notes of 137 ARV-experienced patients selected using a web-based random method from June 2009 – July 2010).
Results
Dizziness (17.40%) was the most frequently reported adverse event in both arms of the study followed by body weakness (11.85%), anemia (11.11%), rash (9.63%), pruritus (9.63%), nausea and vomiting (7.41%) and fatigue (7.41%). Majority of suspected ADRs were mild (76.5%) while only few were severe (3.9%). Female + 3 gender (p=0.0010), CD4 cells count below 200 cells/mm (p=0.0005) and antiretroviral drug combination of Zidovudine + lamivudine + nevirapine (p=0.0099) were significantly associated with the development of ADRs to ARVs.
Conclusion
The most common adverse event to antiretroviral drugs in this study was dizziness followed by body weakness, anaemia, skin rash, body itching, lipodystrophy, nausea and vomiting. Most of the ADRs were mild and their development was significantly associated with female gender, CD4+ cells count below 200 cells/mm3 and antiretroviral drug combination of Zidovudine + lamivudine + nevirapine.
Schlagwörter
Zitieren
APA
Usman, S. O., Oreagba, Ibrahim, Agede, Olalekan, Awodele, O., Ejekam, Chioma, Akinwunmi, A., Adeyemo, T. A., Opanuga, O., Olayemi, S. O., Akanmu, & Sulaimon (2023). Adverse reactions to antiretroviral drugs in patients receiving therapy in a Federal teaching hospital Southwest Nigeria. Afrischolar Discovery. https://doi.org/10.60787/wapcp-25-2-23
Vancouver
Usman SO, Oreagba, Ibrahim, Agede, Olalekan, Awodele O, et al. Adverse reactions to antiretroviral drugs in patients receiving therapy in a Federal teaching hospital Southwest Nigeria. Afrischolar Discovery. 2023. doi:10.60787/wapcp-25-2-23
BibTeX
@article{Usman2023,
author = {Usman, Sikiru Olatunji and Oreagba and Ibrahim and Agede and Olalekan and Awodele, Olufunsho and Ejekam and Chioma and Akinwunmi, Akinyede and Adeyemo, Titilope Adenike and Opanuga, Oluranti and Olayemi, Sunday Oluwafemi and Akanmu and Sulaimon},
title = {Adverse reactions to antiretroviral drugs in patients receiving therapy in a Federal teaching hospital Southwest Nigeria},
journal = {Afrischolar Discovery},
year = {2023},
doi = {10.60787/wapcp-25-2-23}
}
EUVIMED